SYRA HEALTH CORP. Net Change in Cash
SYRA HEALTH CORP. (SYRA) reported Net Change in Cash of $509.01 thousand for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-09-14
- SYRA HEALTH CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was $1.31M, a 1273.80% increase year-over-year.
- SYRA HEALTH CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $95.18K.
- SYRA HEALTH CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$42.12K, a 107.10% decline year-over-year.
- SYRA HEALTH CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $593.07K.
- SYRA HEALTH CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $3.28M.
- SYRA HEALTH CORP. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$96.67K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $509.01K S-1 · filed 2026-09-14 | |||
| 2026-03-31 | $1.31M 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$780.67K S-1 · filed 2026-09-14 | |||
| 2025-09-30 | -$418.86K 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | -$89.48K S-1 · filed 2026-09-14 | |||
| 2025-03-31 | $95.18K 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | -$884.67K S-1 · filed 2026-09-14 | |||
| 2024-09-30 | -$582.62K 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | -$1.69M 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | -$42.12K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $3.28M 10-K · filed 2025-03-11 | |||
| 2023-09-30 | $14.67K 10-Q · filed 2024-10-29 | |||
| 2023-06-30 | $33.10K 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | $593.07K 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$96.67K 10-K · filed 2024-03-25 | |||
| 2022-09-30 | $568.52K 10-Q · filed 2023-11-14 |